✦ LIBER ✦

PMS5 COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS ANTI-TNF MONOCLONAL ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO

✍ Scribed by Aguirre, A; García, E; Bierschwale, H; Arce, CA

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS22 COST-EFFECTIVENESS OF THE USE OF E

✍ X Gao; S Hwang; KT Carpiuc; JM Stephens; R Sato; A Singh; R Rivera; E García; H 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

PMS22 COST-EFFECTIVENESS ANALYSIS OF ETA

✍ J. Vargas-Valencia; M. Sotelo-Guzmán; J.F. Mould-Quevedo; E. Muciño-Ortega; R.M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMS70 COST-EFFECTIVENESS OF ETANERCEPT V

✍ X Gao; S Hwang; KT Carpiuc; JM Stephens; R Sato; A Singh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PMS15 COST-EFFECTIVENESS OF THE TREATMEN

✍ E Mucino; R Rivas; L Zapata 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Clinical efficacy of abatacept, tocilizu

✍ Shinya Hirabara,Nobunori Takahashi,Naoki Fukaya,Hiroyuki Miyake… 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 446 KB

PMS8 Cost-Effectiveness analysis of Etan

✍ Lutz, M.; Cuesta, G.; Morales, G. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB